Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LONRF2 pseudogene 5 (LONRF2P5) is a non-protein-coding genomic sequence homologous to the LONRF2 gene. Pseudogenes like LONRF2P5 may be transcribed into RNA, and, in some cases, their transcripts can regulate cellular processes indirectly by acting as decoys for microRNAs or through other lncRNA-like mechanisms, mostly in the context of cancer. However, there is no evidence that LONRF2P5 is translated into a functional protein, nor is there any clear disease association or pharmacological relevance for this pseudogene. LONRF2P5 is not a molecular target for therapy, and should not be confused with LONRF2, which is a functional ubiquitin ligase involved in protein quality control and motor neuron health.
Not applicable; not a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LONRF2 pseudogene 5 (LONRF2P5).